Monoclonal antibodies are needed globally for research as well as for medical applications within diagnostics and as medicine. Due to high demand, the monoclonal antibodies’ market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.34% to reach US$ 131.7 billion by 2023 from US$ 91.1 billion in 2017.
The major class of nanofibers used in biomedical and healthcare applications are prepared from various natural and synthetic polymers as well as from their composites with inorganic materials. Important biomedical applications of nanofibers include purification, medical textiles, wound healing, tissue engineering and regeneration, biosensors and drug delivery.
Nanomedicine includes several distinct application areas, including drug delivery, in vivo imaging, in vitro diagnostics, biomaterials, and active implants. In these fields, nanomedicine has seen increased research activity during the past decade. Currently, nanomedicine accounts for about 5% of nanotechnology research publications worldwide
To be usable, these antibodies need to be purified from serum, or cell lysates. For this purpose, affinity resins are available, that are used to bind the antibodies, while other contaminations are washed away. The global protein A resin market is expected to reach USD 556.4 million by 2023 from USD 375 million in 2018, growing at a CAGR of 8.2%. The global market for nanofiber products as a whole is estimated to be worth US$ 2.2 billion in total revenues by the end of 2020. The nanomaterials industry is now at the stage of looking for reliable, mass-scale production techniques that would guarantee low prices of produced materials, its well controlled morphology and high level of purity.